|
ZNF318 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.135200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.916580E-01 |
| Normal-vs-Stage2 |
4.708600E-01 |
| Normal-vs-Stage3 |
3.038600E-01 |
| Normal-vs-Stage4 |
5.629600E-02 |
| Stage1-vs-Stage2 |
8.955500E-02 |
| Stage1-vs-Stage3 |
1.621580E-02 |
| Stage1-vs-Stage4 |
5.815500E-04 |
| Stage2-vs-Stage3 |
9.410600E-01 |
| Stage2-vs-Stage4 |
4.249600E-01 |
| Stage3-vs-Stage4 |
3.913200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.473000E-01 |
| Normal-vs-AfricanAmerican |
1.274210E-01 |
| Normal-vs-Asian |
3.016200E-01 |
| Caucasian-vs-AfricanAmerican |
1.085190E-01 |
| Caucasian-vs-Asian |
4.358600E-01 |
| AfricanAmerican-vs-Asian |
1.353170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.057800E-01 |
| Normal-vs-Female |
2.536400E-01 |
| Male-vs-Female |
1.881640E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.032500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.390000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.317400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.714400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.573800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.455700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.328000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.155200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.125600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.991800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.944000E-03 |
| Normal-vs-Grade 2 |
1.841640E-01 |
| Normal-vs-Grade 3 |
5.645800E-01 |
| Normal-vs-Grade 4 |
1.683180E-03 |
| Grade 1-vs-Grade 2 |
7.327700E-02 |
| Grade 1-vs-Grade 3 |
6.738200E-03 |
| Grade 1-vs-Grade 4 |
1.83832999999245E-05 |
| Grade 2-vs-Grade 3 |
2.916400E-02 |
| Grade 2-vs-Grade 4 |
1.38670000005003E-06 |
| Grade 3-vs-Grade 4 |
3.004200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.960300E-04 |
| Normal-vs-ccB subtype |
3.551700E-02 |
| ccA subtype-vs-ccB subtype |
1.99990002336392E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.124600E-01 |
| Normal-vs-N1 |
6.054200E-02 |
| N0-vs-N1 |
9.145800E-02 |
|
|
